Signal from the log
Elucid
55 M$ · Series D and later · United States
Elucid édite Plaque IQ, un logiciel qui lit un scanner coronarien et quantifie la composition de la plaque d'athérome sans passer par un cathéter. La société le présente comme la seule méthode non invasive autorisée par la FDA pour cette mesure. Un quatrième industriel coté est entré au capital, elle ne le nomme pas.
Verified
Announced on , logged by the watch of 2 September 2026.
- Operation
- Funding round
- Announced amount
- 55 M$
- Stage
- Series D and later
- Country
- United States
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Provenance
Source divenewsletter,linkedin
Logged on 2 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.